Kenya has approved the free distribution of the dapivirine vaginal ring, a key tool in the fight against HIV/AIDS, especially for women, who represent the majority of cases in the country. This device, which will be available in 2025, allows women to discreetly reduce their risk of contracting HIV during vaginal intercourse. The move is part of the country’s commitment to diversifying prevention strategies amid a public health crisis affecting more than 1.37 million people, 64% of whom are women.
DRC: Success in the first activation of the Global Health Emergency Corps
The vaginal ring is a monthly device that releases antiretroviral medication inside the vagina, providing an alternative to daily pills or bi-monthly injections. Designed to be practical and discreet, the ring overcomes barriers such as the stigma associated with HIV and the logistical challenges of accessing medical treatment. The World Health Organization endorsed this method in 2021 as an additional tool to prevent infections in women at high risk, and Kenya now joins countries like Botswana, South Africa, and Uganda in its implementation.
Experts recommend using the ring alongside traditional methods, such as condoms, to maximize protection and prevent sexually transmitted infections (STIs). Jonah Onentiah from Kenya’s National AIDS Control Program (NASCOP) noted that this initiative aligns with the goal of reducing new infections, which disproportionately affect women and adolescents. In 2023, over 9,100 new cases were reported in women, compared to 4,100 in men.
The introduction of the ring is expected to transform HIV prevention in Kenya, empowering women to make decisions about their health while addressing social stigmas. Authorities have planned educational campaigns to ensure widespread adoption of this intervention, which could significantly reduce infection rates.
This launch underscores Kenya’s commitment to eradicating the HIV epidemic through innovative and accessible solutions, reinforcing its regional leadership in the fight against this disease.
